McKenzie Moor
Psychiatric/Mental Health · Williston, NDNPI 1205230950
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $792 of the $903 with a category attached, or 87.7%. 12 manufacturers reported payments, led by Alkermes, Inc. at 25.4% of the total.
Across 49 payments — averaging $18.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$229
- Teva Pharmaceuticals USA, Inc.$196
- Takeda Pharmaceuticals U.S.A., Inc.$112
- Sunovion Pharmaceuticals Inc.$77
- AbbVie$66
- Axsome Therapeutics, Inc.$54
- plus $170 from 6 others
What the payments were for
- Food & beverage$79288%
- Education$11112%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$903 in reported general payments places this provider in the 80th percentile of 92 psychiatric/mental health providers in North Dakota.
See all psychiatric/mental health providers in North Dakota →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XanaxAlprazolam | 12 | $4,718 |
| Atomoxetine Hcl | 26 | $3,632 |
| Risperidone | 79 | $1,432 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 34 | $1,179 |
| Vilazodone Hcl | 11 | $575 |
| Mirtazapine | 53 | $562 |
| Lamotrigine | 11 | $526 |
| Duloxetine Hcl | 51 | $517 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 12 | $516 |
| Propranolol Hcl ErPropranolol Hcl | 12 | $504 |
| Divalproex Sodium ErDivalproex Sodium | 21 | $427 |
| Gabapentin | 24 | $366 |
| Aripiprazole | 45 | $315 |
| Guanfacine Hcl ErGuanfacine Hcl | 17 | $249 |
| Quetiapine Fumarate | 21 | $219 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Williston
- Brittany BollingerWilliston$933
- Elizabeth BootsWilliston$567
- Charlotte FerrellWilliston$503
- Jessica Graham SteinhauerFargo$8K
- Madison KirschBismarck$3K
- Roxann BrownMinot$3K
- Rebecca KussJamestown$3K
- Tonya AndersonMinot$3K
- Jennifer WoiwodeMinot$2K
- Linda VolnessFargo$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.